WHC is still in active development. Read this to understand our approach.
depiction of ALFGKMXHOUSVAD-UHFFFAOYSA-N.svg
tripsit

ketobemidone

Verificar en tripsit

isomerdesign

Ketobemidone

Verificar en isomerdesign

drugmap

Ketobemidone

Verificar en drugmap

wiki

Ketobemidone

Verificar en wiki

Data

InChI: InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3

Sinónimos: D08101, 1-Propanone, 1-(4-(m-hydroxyphenyl)-1-methyl-4-piperidyl)-, hydrochloride,Ketobemidone, LS-123062, SCHEMBL9706814, UNII-U9U6LTV80K, Ketobemidone HCl, 5965-49-1, Ketogan (TN), 469-79-4 (Parent), AC1L2YOJ, EINECS 227-749-8, 1-Methyl-4-(m-hydroxyphenyl)piperidine-4-ethylketone hydrochloride, Cliradon hydrochloride,1-[4-(3-Hydroxyphenyl)-1-methyl-4-piperidyl]propan-1-one,Cetobemidone, AC1Q5G7W,kbd,Ketobemidone hydrochloride, Ketobimedon hydrochloride, U9U6LTV80K, 1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]propan-1-one hydrochloride(1:1), DTXSID00208327

Estimated data

Solubilidad: -2.169 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 75.3% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.